From 1999 to 2022, there was a considerable increase in maternal mortality due to cardiovascular disease (CVD).

Maternal influences have a persistent effect on offspring obesity through age 42 years, according to a study published online.

The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.

Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.

Microplastic exposure may increase the risk for chronic diseases, according to a study presented at the annual meeting of the American College of Cardiology.

Engaging in physical activity concentrated within 1 to 2 days is associated with a similar reduction in mortality risk as active regular physical activity.

The long-term incidence of MACE, VTE, and malignancies is low among patients with RA or UC receiving filgotinib, though a slight increase was observed among older patients.

The relationship between depressive symptoms and physical activity in knee osteoarthritis (OA) may vary over time, with initial — but not significant — overall reductions followed by nonlinear ...

Long-term glucocorticoid (GC) use among older adults with late-onset rheumatoid arthritis (LORA) remains prevalent, despite its known adverse effects, according to study results published in ACR Open ...

The US Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and trichomoniasis in women.

The risk for moderate to severe infection in later childhood was associated with overall infection burden in early life.

Although the bivalent COVID-19 vaccine conferred moderate protection against symptomatic disease, hybrid immunity provided the strongest protection.